Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy

Author(s): Ning Zhao, Yeshan Qin, Hongguang Liu*, Zhen Cheng*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 18 , Issue 1 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The aberrant proliferation of tumor cells and abundant vasculature in tumor tissues are closely correlated with receptors that are specifically dysregulated in tumor cells. These tumor-associated targets are critical in early diagnosis and therapy selection. Ligands such as antibodies, proteins, polypeptides and polysaccharides that specifically bind to these targets can significantly improve the detection and cure rate when used as tumor imaging probes or anti-tumor agents. Compared to other targeting ligands, peptides have attracted increasingly more attention in tumor diagnostics and therapeutics because of their small sizes, high affinity, stability, ease of modification and low immunogenicity. Several peptide-based imaging probes and therapeutic agents have already been used in clinical trials. This review summarizes some of the tumor-associated targets and their corresponding peptides, as well as the potential of these peptides in cancer treatment.

Keywords: Tumor, tumor-specific receptor, targeting peptide, diagnostic, Imaging probe, therapeutic, drug delivery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [74 - 86]
Pages: 13
DOI: 10.2174/1871520617666170419143459
Price: $65

Article Metrics

PDF: 232
HTML: 70
PRC: 2